Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis

C. Fabris, D. A. Basso, G. Leandro, T. Meggiato, S. Elba, M. P. Panozzo, G. Del Favero, P. Fogar, F. Di Mario, R. Naccarato

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Serum CA 19-9 and alpha-fetoprotein (AFP) levels were determined in 211 patients with liver cirrhosis and 27 with primary hepatocellular carcinoma (HCC) associated with liver cirrhosis. This was done to determine the usefulness of CA 19-9 level with respect to AFP level in distinguishing between these two illnesses, and to assess the influence of some clinical and biochemical variables on these tests in patients with liver cirrhosis with or without primary HCC. Pathologic AFP values were found in 23 of 27 (sensitivity, 85%) patients with HCC; CA 19-9 levels increased in only 12 of 27 (sensitivity, 44%) HCC patients, the values being comparable with those of patients with liver cirrhosis. In liver cirrhosis a substantial number of false-positive values was found for both markers, although they were higher for CA 19-9 (50 of 211 versus 39 of 211). In liver cirrhosis correlations were found between AFP level and alanine amino-transferase level; and between CA 19-9 level and (1) total bilirubin value, (2) alkaline phosphatase level, and (3) pseudocholinesterase level. The authors conclude that CA 19-9 level is a poor biochemical marker, inferior to AFP level, in the detection of a carcinomatous transformation of liver cirrhosis. The finding of false- positive AFP values in liver cirrhosis seems mainly attributable to cellular proliferation and necrosis. Cholestasis seems to greatly affect serum CA 19-9 level variations, probably by reducing its liver metabolism.

Original languageEnglish
Pages (from-to)1795-1798
Number of pages4
JournalCancer
Volume68
Issue number8
Publication statusPublished - 1991

Fingerprint

alpha-Fetoproteins
Liver Cirrhosis
Hepatocellular Carcinoma
Serum
Pseudocholinesterase
Cholestasis
Liver Neoplasms
Transferases
Bilirubin
Alanine
Alkaline Phosphatase
Necrosis
Biomarkers
Cell Proliferation
Liver

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Fabris, C., Basso, D. A., Leandro, G., Meggiato, T., Elba, S., Panozzo, M. P., ... Naccarato, R. (1991). Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Cancer, 68(8), 1795-1798.

Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. / Fabris, C.; Basso, D. A.; Leandro, G.; Meggiato, T.; Elba, S.; Panozzo, M. P.; Del Favero, G.; Fogar, P.; Di Mario, F.; Naccarato, R.

In: Cancer, Vol. 68, No. 8, 1991, p. 1795-1798.

Research output: Contribution to journalArticle

Fabris, C, Basso, DA, Leandro, G, Meggiato, T, Elba, S, Panozzo, MP, Del Favero, G, Fogar, P, Di Mario, F & Naccarato, R 1991, 'Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis', Cancer, vol. 68, no. 8, pp. 1795-1798.
Fabris C, Basso DA, Leandro G, Meggiato T, Elba S, Panozzo MP et al. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Cancer. 1991;68(8):1795-1798.
Fabris, C. ; Basso, D. A. ; Leandro, G. ; Meggiato, T. ; Elba, S. ; Panozzo, M. P. ; Del Favero, G. ; Fogar, P. ; Di Mario, F. ; Naccarato, R. / Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. In: Cancer. 1991 ; Vol. 68, No. 8. pp. 1795-1798.
@article{2b953d79c6974823a9116b7c09a2c31d,
title = "Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis",
abstract = "Serum CA 19-9 and alpha-fetoprotein (AFP) levels were determined in 211 patients with liver cirrhosis and 27 with primary hepatocellular carcinoma (HCC) associated with liver cirrhosis. This was done to determine the usefulness of CA 19-9 level with respect to AFP level in distinguishing between these two illnesses, and to assess the influence of some clinical and biochemical variables on these tests in patients with liver cirrhosis with or without primary HCC. Pathologic AFP values were found in 23 of 27 (sensitivity, 85{\%}) patients with HCC; CA 19-9 levels increased in only 12 of 27 (sensitivity, 44{\%}) HCC patients, the values being comparable with those of patients with liver cirrhosis. In liver cirrhosis a substantial number of false-positive values was found for both markers, although they were higher for CA 19-9 (50 of 211 versus 39 of 211). In liver cirrhosis correlations were found between AFP level and alanine amino-transferase level; and between CA 19-9 level and (1) total bilirubin value, (2) alkaline phosphatase level, and (3) pseudocholinesterase level. The authors conclude that CA 19-9 level is a poor biochemical marker, inferior to AFP level, in the detection of a carcinomatous transformation of liver cirrhosis. The finding of false- positive AFP values in liver cirrhosis seems mainly attributable to cellular proliferation and necrosis. Cholestasis seems to greatly affect serum CA 19-9 level variations, probably by reducing its liver metabolism.",
author = "C. Fabris and Basso, {D. A.} and G. Leandro and T. Meggiato and S. Elba and Panozzo, {M. P.} and {Del Favero}, G. and P. Fogar and {Di Mario}, F. and R. Naccarato",
year = "1991",
language = "English",
volume = "68",
pages = "1795--1798",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis

AU - Fabris, C.

AU - Basso, D. A.

AU - Leandro, G.

AU - Meggiato, T.

AU - Elba, S.

AU - Panozzo, M. P.

AU - Del Favero, G.

AU - Fogar, P.

AU - Di Mario, F.

AU - Naccarato, R.

PY - 1991

Y1 - 1991

N2 - Serum CA 19-9 and alpha-fetoprotein (AFP) levels were determined in 211 patients with liver cirrhosis and 27 with primary hepatocellular carcinoma (HCC) associated with liver cirrhosis. This was done to determine the usefulness of CA 19-9 level with respect to AFP level in distinguishing between these two illnesses, and to assess the influence of some clinical and biochemical variables on these tests in patients with liver cirrhosis with or without primary HCC. Pathologic AFP values were found in 23 of 27 (sensitivity, 85%) patients with HCC; CA 19-9 levels increased in only 12 of 27 (sensitivity, 44%) HCC patients, the values being comparable with those of patients with liver cirrhosis. In liver cirrhosis a substantial number of false-positive values was found for both markers, although they were higher for CA 19-9 (50 of 211 versus 39 of 211). In liver cirrhosis correlations were found between AFP level and alanine amino-transferase level; and between CA 19-9 level and (1) total bilirubin value, (2) alkaline phosphatase level, and (3) pseudocholinesterase level. The authors conclude that CA 19-9 level is a poor biochemical marker, inferior to AFP level, in the detection of a carcinomatous transformation of liver cirrhosis. The finding of false- positive AFP values in liver cirrhosis seems mainly attributable to cellular proliferation and necrosis. Cholestasis seems to greatly affect serum CA 19-9 level variations, probably by reducing its liver metabolism.

AB - Serum CA 19-9 and alpha-fetoprotein (AFP) levels were determined in 211 patients with liver cirrhosis and 27 with primary hepatocellular carcinoma (HCC) associated with liver cirrhosis. This was done to determine the usefulness of CA 19-9 level with respect to AFP level in distinguishing between these two illnesses, and to assess the influence of some clinical and biochemical variables on these tests in patients with liver cirrhosis with or without primary HCC. Pathologic AFP values were found in 23 of 27 (sensitivity, 85%) patients with HCC; CA 19-9 levels increased in only 12 of 27 (sensitivity, 44%) HCC patients, the values being comparable with those of patients with liver cirrhosis. In liver cirrhosis a substantial number of false-positive values was found for both markers, although they were higher for CA 19-9 (50 of 211 versus 39 of 211). In liver cirrhosis correlations were found between AFP level and alanine amino-transferase level; and between CA 19-9 level and (1) total bilirubin value, (2) alkaline phosphatase level, and (3) pseudocholinesterase level. The authors conclude that CA 19-9 level is a poor biochemical marker, inferior to AFP level, in the detection of a carcinomatous transformation of liver cirrhosis. The finding of false- positive AFP values in liver cirrhosis seems mainly attributable to cellular proliferation and necrosis. Cholestasis seems to greatly affect serum CA 19-9 level variations, probably by reducing its liver metabolism.

UR - http://www.scopus.com/inward/record.url?scp=0026326757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026326757&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - 1795

EP - 1798

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 8

ER -